Predictors of Quality of Life Decline in Patients with Oligometastases treated with Stereotactic Ablative Radiotherapy: Analysis of the Population-Based SABR-5 Phase II Trial

This study aimed to identify risk factors for QoL decline.

Source: Clinical Oncology - January 17, 2024 Category: Radiology Authors: E.M. Cruz-Lim, B. Mou, W. Jiang, M. Liu, A. Bergman, D. Schellenberg, A. Alexander, T. Berrang, A. Bang, N. Chng, Q. Matthews, H. Carolan, F. Hsu, S. Miller, S. Atrchian, E. Chan, C. Ho, I. Mohamed, A. Lin, V. Huang, A. Mestrovic, D. Hyde, C. Lund, H. Pai Tags: Original Article Source Type: research